Literature DB >> 8580557

Leukemia developing after 131I treatment for thyroid cancer in a patient with Werner's syndrome: molecular and cytogenetic studies.

Y Takemoto1, T Hata, K Kamino, N Mitsuda, T Miki, H Kawagoe, T Ogihara.   

Abstract

A 40-year-old female patient with Werner's syndrome (WS) suffering from thyroid cancer and myelodysplastic syndrome (MDS) is reported. She had been diagnosed as having WS complicated with thyroid cancer seven years previously. Total thyroidectomy and radioactive iodine (131I, 100 mCi/year) therapy for seven years had slowed the progression of thyroid cancer. She suffered a sudden onset of MDS at the age of 40 years. After six months she died from overt leukemia. We found an additional chromosome aberration of chromosome 10 in the progression of leukemia from MDS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8580557     DOI: 10.2169/internalmedicine.34.863

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  How breast cancer chemotherapy increases the risk of leukemia: Thoughts about a case of diffuse large B-cell lymphoma and leukemia after breast cancer chemotherapy.

Authors:  Bin Zhang; Xia Zhang; Minghuan Li; Li Kong; Xiaoqin Deng; Jinming Yu
Journal:  Cancer Biol Ther       Date:  2016-02-09       Impact factor: 4.742

2.  Hereditary cancer syndrome-associated pathogenic variants are common in patients with hematologic malignancies subsequent to primary solid cancer.

Authors:  Joowon Oh; Yu Ri Kim; Yoonjung Kim; Boyeon Kim; Kyung Sun Park; Seong-Hyeuk Nam; Kyung-A Lee
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.